The pathways contributing to cancer development and the PI3K/AKT signaling pathway showed a high correlation in both GO and KEGG analyses results, implying that these pathways might be closely linked to the pharmacological activities of TFDR involved in improving GIOP. The gene discussed is AKT1; the disease is cancer.